Anneleen Daemen

Company: ORIC Pharmaceuticals

Job title: Executive Director, Translational Medicine & Head of Bioinformatics

Seminars:

Multi-Analytes Analysis in Prostate Cancer: Overcoming Tumor Heterogeneity Challenges with Liquid Biopsy 6:00 pm

Impact of tumor heterogeneity on drug development and patient selection Advantages of a multi-analyte biomarker approach in a phase 1 trial Opportunity, and challenges, of precision medicine for prostate cancerRead more

day: Day One Track A (2)